These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 19703350)

  • 1. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
    Banti I; Nencetti S; Orlandini E; Lapucci A; Breschi MC; Fogli S
    J Pharm Pharmacol; 2009 Aug; 61(8):1057-66. PubMed ID: 19703350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
    Kumar V; Madaan A; Sanna VK; Vishnoi M; Joshi N; Singh AT; Jaggi M; Sharma PK; Irchhaiya R; Burman AC
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
    Al-Saadi MS; Rostom SA; Faidallah HM
    Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
    Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
    Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
    Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles.
    Ziedan NI; Stefanelli F; Fogli S; Westwell AD
    Eur J Med Chem; 2010 Oct; 45(10):4523-30. PubMed ID: 20705365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
    Dai H; Li R; Wheeler T; Ozen M; Ittmann M; Anderson M; Wang Y; Rowley D; Younes M; Ayala GE
    Hum Pathol; 2007 Feb; 38(2):299-307. PubMed ID: 17097719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cytotoxic rosamine derivatives selectively accumulate in the mitochondria of cancer cells.
    Lim SH; Wu L; Burgess K; Lee HB
    Anticancer Drugs; 2009 Jul; 20(6):461-8. PubMed ID: 19387338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives.
    Srivastava SK; Jaggi M; Singh AT; Madan A; Rani N; Vishnoi M; Agarwal SK; Mukherjee R; Burman AC
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6660-4. PubMed ID: 17950602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
    Kumar V; Jaggi M; Singh AT; Madaan A; Sanna V; Singh P; Sharma PK; Irchhaiya R; Burman AC
    Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A.
    Li X; Roginsky AB; Ding XZ; Woodward C; Collin P; Newman RA; Bell RH; Adrian TE
    Ann N Y Acad Sci; 2008 Sep; 1138():181-98. PubMed ID: 18837899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest.
    Ujiki MB; Milam B; Ding XZ; Roginsky AB; Salabat MR; Talamonti MS; Bell RH; Gu W; Silverman RB; Adrian TE
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1224-8. PubMed ID: 16414351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
    Zhang D; Ma Q; Shen S; Hu H
    Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.
    Manera C; Saccomanni G; Adinolfi B; Benetti V; Ligresti A; Cascio MG; Tuccinardi T; Lucchesi V; Martinelli A; Nieri P; Masini E; Di Marzo V; Ferrarini PL
    J Med Chem; 2009 Jun; 52(12):3644-51. PubMed ID: 19435366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.
    Ibáñez E; Plano D; Font M; Calvo A; Prior C; Palop JA; Sanmartín C
    Eur J Med Chem; 2011 Jan; 46(1):265-74. PubMed ID: 21115210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells.
    Fogli S; Banti I; Stefanelli F; Picchianti L; Digiacomo M; Macchia M; Breschi MC; Lapucci A
    Eur J Med Chem; 2010 Nov; 45(11):5100-7. PubMed ID: 20801552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.